Perceptive Advisors - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q4 2021$19,800,000
+65.1%
705,608
+100.0%
0.15%
-12.1%
Q3 2021$11,992,000
-58.4%
352,804
-50.0%
0.17%
-7.0%
Q2 2021$28,832,000
+103.0%
705,608
+100.0%
0.19%
+3.9%
Q1 2021$14,204,000
-73.5%
352,804
-61.0%
0.18%
-68.6%
Q4 2020$53,504,000
+32.6%
904,854
+9.0%
0.57%
-2.5%
Q3 2020$40,363,000
+73.8%
830,000
+72.9%
0.59%
+56.6%
Q2 2020$23,222,000
+73.0%
480,000
-3.0%
0.38%
+7.4%
Q1 2020$13,424,000
+47.1%
495,000
+62.3%
0.35%
+93.4%
Q4 2019$9,126,000
+0.1%
305,000
+3.4%
0.18%
-26.4%
Q3 2019$9,116,000
-33.8%
295,000
+3.5%
0.25%
-22.2%
Q2 2019$13,766,000285,0000.32%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders